Stockscreener 앱 받기
0.425
5.56%
-0.025
시간 외 거래:
.41
-0.015
-3.53%
전일 마감가:
$0.45
열려 있는:
$0.4462
하루 거래량:
96,363
Relative Volume:
0.03
시가총액:
$12.04M
수익:
-
순이익/손실:
$-1.29M
주가수익비율:
-9.2795
EPS:
-0.0458
순현금흐름:
$-9.72M
1주 성능:
+10.45%
1개월 성능:
+32.90%
6개월 성능:
-64.29%
1년 성능:
+0.00%
1일 변동 폭
$0.40
$0.4462
1주일 범위
$0.38
$0.45
52주 변동 폭
$0.262
$9.1796
Curanex Pharmaceuticals Inc Stock (CURX) Company Profile
명칭
Curanex Pharmaceuticals Inc
전화
718-673-6078
주소
2 JERICHO PLAZA,, JERICHO
Compare CURX vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CURX
Curanex Pharmaceuticals Inc
|
0.425 | 12.75M | 0 | -1.29M | -9.72M | -0.0458 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Curanex Pharmaceuticals Inc 주식(CURX)의 최신 뉴스
Nasdaq tumbles over 350 points; US initial jobless claims increase - MSN
Curanex Pharmaceuticals IncTargets Ind Submission For Phyto-N In Q4 2026 - TradingView
Botanical drug used in China for 30 years clears key U.S. safety test - Stock Titan
Curanex adds two pharmaceutical veterans to advisory board By Investing.com - Investing.com Nigeria
CURX Should I Buy - Intellectia AI
Curanex adds two advisors to scientific board ahead of IND filing By Investing.com - Investing.com India
Curanex adds two advisors to scientific board ahead of IND filing - Investing.com Australia
Curanex Expands Scientific Advisory Board With Two Distinguished Researchers - Bitget
TB and COVID scientists join Curanex board to steer 2026 trial plans - Stock Titan
Curanex adds two pharmaceutical veterans to advisory board - Investing.com India
Curanex Appoints Two Veteran Industry Leaders to Scientific Advisory Board - marketscreener.com
Veteran drug creators with HIV, HCV medicines join Curanex - Stock Titan
Curanex Formalizes Long-Term Executive Employment and Compensation Agreements - TipRanks
Curanex Pharmaceuticals Inc Enters into Executive Employment Agreement with Jun Liu as President and Chairman of the Board, Effective March 1, 2026 - marketscreener.com
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Curanex Forms World Class Scientific Advisory Board - Bitget
Botanical drug firm Curanex taps Fortune 100 pharma exec to guide R&D - Stock Titan
Curanex Pharmaceuticals Inc (CURX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Stocks in the News: ALBT, NDRA, CURX, HCTIAI, Clinical Milestones Drive Market Surges - marketscreener.com
Market Movers | Winners: IXHL, ALBT, RXT | Losers: THRY, EOSE, ERII - Trefis
Thursday's session: most active stocks - ChartMill
Unusual volume stocks are being observed in Thursday's session. - ChartMill
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Why Marriott Vacations Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket - Benzinga
Curanex Pharmaceuticals Stock Soars 56.32% After Key IND Milestone - Intellectia AI
24,000,000 Common Stock of Curanex Pharmaceuticals Inc are subject to a Lock-Up Agreement Ending on 26-FEB-2026. - marketscreener.com
Top movers in Wednesday's after hours session - ChartMill
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Curanex completes GMP pilot batch for ulcerative colitis drug - Investing.com
Curanex Completes GMP Pilot For Phyto-N, Targets IND Submission In Ulcerative Colitis - Nasdaq
Curanex provides operational update on key regulatory milestones - marketscreener.com
Curanex completes GMP pilot batch for ulcerative colitis drug By Investing.com - Investing.com South Africa
Curanex Provides Operational Update on Key Regulatory Milestones - GlobeNewswire
Comparing Curanex Pharmaceuticals (CURX) & The Competition - Defense World
Curanex Pharmaceuticals (CURX) versus Its Peers Financial Survey - Defense World
Financial Contrast: Curanex Pharmaceuticals (CURX) & Its Peers - Defense World
Curanex Pharmaceuticals appoints new chief financial officer - MSN
Contrasting Curanex Pharmaceuticals (CURX) and The Competition - Defense World
Curanex Pharmaceuticals appoints Wanjun Zhang as CFO following resignation By Investing.com - Investing.com Nigeria
Curanex Pharmaceuticals appoints Wanjun Zhang as CFO following resignation - Investing.com
Curanex Pharmaceuticals (CURX) Competitors and Alternatives 2026 - MarketBeat
Curanex Pharmaceuticals Inc (CURX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):